New drug aims to tame rare autoimmune disease
NCT ID NCT06046222
Summary
This study is testing whether an investigational drug called NS-229 can help control a rare autoimmune disease called EGPA. It will compare NS-229 to a placebo in 45 adults who are already taking steroid medication. The main goal is to see if patients can achieve disease remission while reducing their steroid dose over 28 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Addenbrookes Hospital
RECRUITINGCambridge, CB2 2QQ, United Kingdom
-
Azienda Ospedaliera Universitaria Integrata Verona
RECRUITINGVerona, 37126, Italy
-
Azienda Provinciale per i Servizi Sanitari Provincia Autonoma Trento
RECRUITINGTrento, 38122, Italy
-
CHU Nice
RECRUITINGNice, 06202, France
-
Chiba University Hospital
RECRUITINGChuo-ku, Chiba-shi, Chiba, 260-8677, Japan
-
Chu Rangueil
RECRUITINGToulouse, 31059, France
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
-
Complejo Hospitalario Universitario de Santiago de Compostela
ACTIVE_NOT_RECRUITINGSantiago de Compostela, A Coruna, 15706, Spain
-
Complejo Hospitalario de Navarra
ACTIVE_NOT_RECRUITINGPamplona, 31008, Spain
-
Fondazione Policlinico Universitario Campus Bio-Medico
RECRUITINGRoma, 00128, Italy
-
Hokkaido University Hospital
RECRUITINGSapporo, Hokkaido, 060-8648, Japan
-
Hopital Cochin
RECRUITINGParis, 75014, France
-
Hospital of the University of Occupational and Environmental Health, Japan
RECRUITINGKitakyushu, Fukuoka, 807-8555, Japan
-
Istituto Auxologico Italiano IRCCS
RECRUITINGMilan, 20145, Italy
-
Juntendo University Hospital
RECRUITINGBunkyo-ku, Tokyo, 113-8431, Japan
-
Kyorin University Hospital
RECRUITINGMitaka, Tokyo, 181-8611, Japan
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
-
Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29425, United States
-
Medius Kliniken gGmbh
RECRUITINGKirchheim unter Teck, Studienzentrale, 73230, Germany
-
NHO Sagamihara National Hospital
RECRUITINGSagamihara, Kanagawa, 252-0392, Japan
-
National Hospital Organization Yokohama Medical Center
RECRUITINGYokohama, Kanagawa, 245-8575, Japan
-
National Jewish Health
RECRUITINGDenver, Colorado, 80206, United States
-
Osaka Habikino Medical Center
RECRUITINGHabikino, Osaka, 583-8588, Japan
-
Queen Elizabeth Hospital Birmingham
RECRUITINGEdgbaston, Birmingham, B15 2GW, United Kingdom
-
Royal Berkshire NHS Foundation Trust
RECRUITINGReading, RG1 5AN, United Kingdom
-
Saitama Medical Center
RECRUITINGKawagoe, Saitama, 350-8550, Japan
-
St Joseph's Healthcare Hamilton
ACTIVE_NOT_RECRUITINGHamilton, Ontario, L8N4A6, Canada
-
The Ohio State University Wexner Medical Center
RECRUITINGColumbus, Ohio, 43210, United States
-
Toho University Omori Medical Center
RECRUITINGŌta-ku, Tokyo, 143-8541, Japan
-
Tohoku University Hospital
RECRUITINGSendai, Miyagi, 980-8574, Japan
-
University of Alberta
RECRUITINGEdmonton, Alberta, T6G 2B7, Canada
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
University of Toronto
RECRUITINGToronto, Ontario, M5G 1X5, Canada
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.